Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Chubb
Federal Trade Commission
McKinsey
Colorcon
Farmers Insurance
Citi
Mallinckrodt

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078718

« Back to Dashboard

NDA 078718 describes DEFEROXAMINE MESYLATE, which is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Watson Labs, and West-ward Pharms Int, and is included in five NDAs. It is available from five suppliers. Additional details are available on the DEFEROXAMINE MESYLATE profile page.

The generic ingredient in DEFEROXAMINE MESYLATE is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
Summary for 078718
Tradename:DEFEROXAMINE MESYLATE
Applicant:Fresenius Kabi Usa
Ingredient:deferoxamine mesylate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 078718
Mechanism of ActionIron Chelating Activity
Medical Subject Heading (MeSH) Categories for 078718
Suppliers and Packaging for NDA: 078718
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 078718 ANDA Fresenius Kabi USA, LLC 63323-597 N 63323-597-10
DEFEROXAMINE MESYLATE deferoxamine mesylate INJECTABLE;INJECTION 078718 ANDA Fresenius Kabi USA, LLC 63323-599 N 63323-599-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Sep 15, 2009TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2GM/VIAL
Approval Date:Sep 15, 2009TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
US Department of Justice
Dow
US Army
Daiichi Sankyo
Cipla
Boehringer Ingelheim
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.